A Study to Evaluate the Safety and Clinical Efficacy of STR-P004
NCT07003178
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Non Hodgkin Lymphoma
Interventions
DRUG:
STR-P004
Sponsor
Starna Therapeutics